Wuping Wang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Supercapacitor Materials and Fabrication
Papers in
-
- Tracheal and airway disorders 5
- Lung Cancer Treatments and Mutations 4
- Surgery 12
- Esophageal and GI Pathology 5
- Esophageal Cancer Research and Treatment 4
- Co-authors
- Qiang Lü (9 shared papers)Yunfeng Ni (11 shared papers)Ming-Qiang Zhu (2 shared papers)Jie Cheng (2 shared papers)Sheng-Chun Hu (2 shared papers)Xiaohua Huang (2 shared papers)Guotao Sun (1 shared paper)Lile Hu (1 shared paper)
In The Last Decade
Wuping Wang
42 papers receiving 464 citations
Peers
Comparison fields: 5 of 98
- Cancer Research 64
- Electronic, Optical and Magnetic Materials 68
- Biomaterials 45
- Oncology 82
- Pulmonary and Respiratory Medicine 96
Countries citing papers authored by Wuping Wang
This map shows the geographic impact of Wuping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wuping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wuping Wang more than expected).
Fields of papers citing papers by Wuping Wang
This network shows the impact of papers produced by Wuping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wuping Wang. The network helps show where Wuping Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wuping Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 95 | |
| 2 | 2020 | 44 | |
| 3 | Inhibiting CREPT reduces the proliferation and migration of non-small cell lung cancer cells by down-regulating cell cycle related protein. | 2016 | 26 |
| 4 | 2016 | 24 | |
| 5 | 2016 | 24 | |
| 6 | 2016 | 23 | |
| 7 | 2016 | 21 | |
| 8 | 2020 | 20 | |
| 9 | 2015 | 18 | |
| 10 | 2012 | 14 | |
| 11 | 2021 | 14 | |
| 12 | 2016 | 13 | |
| 13 | 2012 | 12 | |
| 14 | Crocin attenuates lipopolysacchride-induced acute lung injury in mice. | 2015 | 11 |
| 15 | 2013 | 11 | |
| 16 | 2012 | 9 | |
| 17 | 2021 | 9 | |
| 18 | 2022 | 9 | |
| 19 | 2015 | 8 | |
| 20 | 2023 | 6 |
About Wuping Wang
Wuping Wang is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Oncology and Cancer Research, having authored 45 papers that have together received 473 indexed citations. Recurring topics across this work include Tracheal and airway disorders (5 papers), Esophageal and GI Pathology (5 papers), MicroRNA in disease regulation (5 papers), Advancements in Photolithography Techniques (4 papers), Esophageal Cancer Research and Treatment (4 papers), Cancer-related molecular mechanisms research (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (64 citations), Electronic, Optical and Magnetic Materials (68 citations), Biomaterials (45 citations), Oncology (82 citations) and Pulmonary and Respiratory Medicine (96 citations). Wuping Wang has collaborated with scholars based in China, Hong Kong and Norway. Frequent co-authors include Qiang Lü, Yunfeng Ni, Ming-Qiang Zhu, Jie Cheng, Sheng-Chun Hu, Xiaohua Huang, Guotao Sun, Lile Hu, Xiaofei Li and Zhipei Zhang. Their work appears in journals such as Disease Markers, Frontiers in Oncology, Biomarkers, Frontiers in Cell and Developmental Biology and Renewable Energy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.